Related Experiment Video
Updated: May 16, 2025
Author Spotlight: Exploring Advanced Therapeutic Targets in Osteosarcoma Through Spatial Transcriptomics
Published on: May 3, 2024
Spatial Profiling Identifies Regionally Distinct Microenvironments and Targetable Immunosuppressive Mechanisms in
Jason Eigenbrood1, Nathan Wong2,3, Paul Mallory4
1Pediatric Oncology Branch, National Cancer Institute, Bethesda, Maryland.
Abstract:
Osteosarcoma is the most common malignant bone tumor in young patients and remains a significant clinical challenge, particularly at the metastatic stage. Studies detailing the immunosuppressive mechanisms within the metastatic osteosarcoma microenvironment are needed to elucidate the cellular communities in the metastatic microenvironment that support metastatic growth and to identify therapeutic approaches to target the cross-talk between cancer cells and their microenvironment. In this study, we performed spatial transcriptional profiling on a cohort of osteosarcoma pulmonary metastases from pediatric patients. The data revealed a conserved spatial gene expression pattern resembling a foreign body granuloma, characterized by peripheral inflammatory signaling, fibrocollagenous encapsulation, lymphocyte exclusion, and peritumoral macrophage accumulation. The intratumoral microenvironment of these lesions, however, lacked inflammatory signaling. Exploration of spatially distinct drug-gene interactions identified the CXCR4 signaling axis, which displayed spatial heterogeneity and complexity, as a potential therapeutic target that bridges both the intra- and extratumoral microenvironments. Collectively, this study reveals that metastatic osteosarcoma comprises multiple regionally distinct immunosuppressive microenvironments.
Significance:
Exploration of spatially resolved microenvironments in metastatic osteosarcoma tissues reveals how the tissue architecture promotes immunosuppression and identifies actionable processes to enhance immunotherapy efficacy.
Insights
Metastatic osteosarcoma features distinct immunosuppressive microenvironments, resembling granulomas. Targeting the CXCR4 signaling axis may offer a novel therapeutic strategy for these challenging pediatric bone cancers.
Area of Science:
- Oncology
- Immunology
- Genomics
Background:
- Osteosarcoma is a prevalent pediatric bone cancer, with metastasis posing a major clinical challenge.
- Understanding the immunosuppressive tumor microenvironment is crucial for developing effective treatments for metastatic osteosarcoma.
Purpose of the Study:
- To investigate the spatial organization and cellular communities within pediatric osteosarcoma pulmonary metastases.
- To identify therapeutic targets within the tumor microenvironment that mediate cancer cell-stromal interactions.
Main Methods:
- Spatial transcriptional profiling of osteosarcoma pulmonary metastases from pediatric patients.
- Analysis of gene expression patterns to identify distinct microenvironmental niches.
- Exploration of spatially resolved drug-gene interactions.
Main Results:
- A conserved foreign body granuloma-like gene expression pattern was observed in the metastatic periphery.
- Distinct intratumoral and extratumoral microenvironments were identified, with differences in inflammatory signaling.
- The CXCR4 signaling axis showed spatial heterogeneity and emerged as a potential therapeutic target.
Conclusions:
- Metastatic osteosarcoma microenvironments are regionally distinct and immunosuppressive.
- The CXCR4 signaling pathway represents a promising target for therapeutic intervention in metastatic osteosarcoma.
More Related Videos
04:25Intratibial Osteosarcoma Cell Injection to Generate Orthotopic Osteosarcoma and Lung Metastasis Mouse Models
Published on: October 28, 2021
07:44Practical Considerations in Studying Metastatic Lung Colonization in Osteosarcoma Using the Pulmonary Metastasis Assay
Published on: March 12, 2018